Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qipeng Chai

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Scientific Reports|June 13, 2015
Rational molecular engineering of cyclopentadithiophene-bridged D-A-π-A sensitizers combining high photovoltaic efficiency with rapid dye adsorptionQipeng Chai, Wenqin Li, Jingchuan Liu, et al.
ACS Applied Materials & Interfaces|July 26, 2014
Effect of a long alkyl group on cyclopentadithiophene as a conjugated bridge for D-A-π-A organic sensitizers: IPCE, electron diffusion length, and charge recombinationQipeng Chai, Wenqin Li, Yongzhen Wu, et al.
Journal of Medicinal Chemistry|July 18, 2023
Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma ActivityFengling Liu, Chunxi Liu, Qipeng Chai, et al.
ACS Applied Materials & Interfaces|November 11, 2015
Rational Molecular Engineering of Indoline-Based D-A-π-A Organic Sensitizers for Long-Wavelength-Responsive Dye-Sensitized Solar CellsWeiwei Zhang, Yongzhen Wu, Haibo Zhu, et al.
Bioorganic Chemistry|November 21, 2024
Discovery of epigenetic modulators targeting HDACs and EZH2 simultaneously for the treatment of hematological malignanciesJinwei Zhang, Maoshuo Yang, Qian Liu, et al.
Journal of Medicinal Chemistry|October 5, 2023
Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast CancerChunlong Zhao, Yu Zhang, Jin'ge Zhang, et al.
Journal of Medicinal Chemistry|March 6, 2026
Discovery of a Hydroxamic Acid-Based HDAC11 Isoform-Selective Inhibitor with Oral Anti-AML PotencyQipeng Chai, Maoshuo Yang, Chunxi Liu, et al.
Journal of Medicinal Chemistry|April 3, 2025
HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism InvestigationMaoshuo Yang, Wei Zhao, Jinwei Zhang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Scientific Reports|June 13, 2015
Rational molecular engineering of cyclopentadithiophene-bridged D-A-π-A sensitizers combining high photovoltaic efficiency with rapid dye adsorptionQipeng Chai, Wenqin Li, Jingchuan Liu, et al.
ACS Applied Materials & Interfaces|July 26, 2014
Effect of a long alkyl group on cyclopentadithiophene as a conjugated bridge for D-A-π-A organic sensitizers: IPCE, electron diffusion length, and charge recombinationQipeng Chai, Wenqin Li, Yongzhen Wu, et al.
Journal of Medicinal Chemistry|July 18, 2023
Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma ActivityFengling Liu, Chunxi Liu, Qipeng Chai, et al.
ACS Applied Materials & Interfaces|November 11, 2015
Rational Molecular Engineering of Indoline-Based D-A-π-A Organic Sensitizers for Long-Wavelength-Responsive Dye-Sensitized Solar CellsWeiwei Zhang, Yongzhen Wu, Haibo Zhu, et al.
Bioorganic Chemistry|November 21, 2024
Discovery of epigenetic modulators targeting HDACs and EZH2 simultaneously for the treatment of hematological malignanciesJinwei Zhang, Maoshuo Yang, Qian Liu, et al.
Journal of Medicinal Chemistry|October 5, 2023
Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast CancerChunlong Zhao, Yu Zhang, Jin'ge Zhang, et al.
Journal of Medicinal Chemistry|March 6, 2026
Discovery of a Hydroxamic Acid-Based HDAC11 Isoform-Selective Inhibitor with Oral Anti-AML PotencyQipeng Chai, Maoshuo Yang, Chunxi Liu, et al.
Journal of Medicinal Chemistry|April 3, 2025
HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism InvestigationMaoshuo Yang, Wei Zhao, Jinwei Zhang, et al.
Pageof 1